Literature DB >> 20480794

A comparative study evaluating the tolerability and efficacy of two topical therapies for the treatment of keloids and hypertrophic scars.

Oliver A Perez1, Martha H Viera, Jitendra K Patel, Sailesh Konda, Sadegh Amini, Ran Huo, Deborah Zell, Sujatha Tadicherla, Brian Berman.   

Abstract

BACKGROUND: Onion extract gel (OE) and 0.5% hydrocortisone, silicone and vitamin E lotion (HSE) are two over-the-counter preparations used to enhance the cosmesis of keloids and hypertrophic scars.
OBJECTIVE: To determine the tolerability and efficacy of OE versus HSE versus placebo in subjects with keloids and hypertrophic scars.
METHODS: Thirty subjects (> or =18 years) with keloids or hypertrophic scars were randomly assigned to one of three study preparations for 16 weeks. Scar volume was measured at baseline and weeks 4, 8, 12 and 16. Subjects and blinded investigators assessed scar parameters (induration, erythema, pigmentation alteration, pain, itching, tenderness and cosmetic appearance) and patient satisfaction at each visit using a visual analog scale (VAS). Data analysis included: mean percentage change (MPC) for subjects completing the study (n = 15); the mixed model test to determine differences between the groups over time; and the Kruskal-Wallis test for the analysis of differences in subjects' satisfaction within the three groups over 16 weeks for subjects who completed at least one follow-up visit (n = 21).
RESULTS: All three preparations were well tolerated with the exception of a mild acneiform-like eruption in one OE patient. Significant improvements were obtained with OE in volume, length, width and induration and with HSE in volume, length, induration, erythema and pigmentation alteration. There was a trend showing that a higher percentage of subjects were satisfied with OE than with HSE or placebo. The Mix Model Analysis (MMA) showed significant improvements with OE over placebo in investigator cosmetic assessment, lesion induration, pigmentation and tenderness and with HSE over placebo in investigator cosmetic assessment, lesion induration, pigmentation and erythema. Improvements in erythema and pigmentation were significantly greater in HSE than in OE.
CONCLUSION: Both OE and HSE were more effective than placebo in the management of hypertrophic scars and keloids.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20480794

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  6 in total

1.  A new proprietary onion extract gel improves the appearance of new scars: a randomized, controlled, blinded-investigator study.

Authors:  Zoe D Draelos; Leslie Baumann; Alan B Fleischer; Stefan Plaum; Edward V Avakian; Bhushan Hardas
Journal:  J Clin Aesthet Dermatol       Date:  2012-06

2.  An evaluation of evidence regarding application of silicone gel sheeting for the management of hypertrophic scars and keloids.

Authors:  Morgan McCarty
Journal:  J Clin Aesthet Dermatol       Date:  2010-11

Review 3.  Emerging Therapies for Scar Prevention.

Authors:  Lisa Block; Ankush Gosain; Timothy W King
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-10-01       Impact factor: 4.730

Review 4.  A comprehensive evidence-based review on the role of topicals and dressings in the management of skin scarring.

Authors:  G P Sidgwick; D McGeorge; A Bayat
Journal:  Arch Dermatol Res       Date:  2015-06-05       Impact factor: 3.017

Review 5.  Allium cepa: A Treasure of Bioactive Phytochemicals with Prospective Health Benefits.

Authors:  Arka Jyoti Chakraborty; Tanvir Mahtab Uddin; B M Redwan Matin Zidan; Saikat Mitra; Rajib Das; Firzan Nainu; Kuldeep Dhama; Arpita Roy; Md Jamal Hossain; Ameer Khusro; Talha Bin Emran
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-18       Impact factor: 2.629

6.  Polydeoxyribonucleotide for the improvement of a hypertrophic retracting scar-An interesting case report.

Authors:  Magda Belmontesi
Journal:  J Cosmet Dermatol       Date:  2020-09-21       Impact factor: 2.696

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.